State Override Statutes · Clinical Exceptions
Overriding step therapy for GLP-1 medications
Insurance plans often demand you "fail first" on older, cheaper drugs (metformin, phentermine, or older GLP-1s) before approving Zepbound or Wegovy. Most states have enacted some form of step-therapy reform, and even where no statute applies, plan exception procedures recognize the same clinical grounds.
The Strategy in One Minute
Insurance plans often demand you "fail first" on older, cheaper drugs before approving newer GLP-1s. But most states have enacted step-therapy reform statutes, and the clinical exception grounds they codify are the same ones plan formulary-exception procedures recognize everywhere else — so the physician attestation below works in either regime.
PBMs demand trial and failure on 1 to 3 older medications (such as phentermine or metformin) before approving Zepbound or Wegovy.
Physician attests contraindication, past intolerance, or stable therapy. Where a state statute applies, it comes with a decision deadline; elsewhere the plan's own exception process handles the same request.
The 5 Legal Grounds for a Step Therapy Exception
These are the grounds the model step-therapy legislation codifies and most enacted statutes follow; plan exception guidelines recognize the same five. Where a statute applies, the plan must grant the exception if your prescriber certifies one of them:
- 1. Contraindication
- The required step-1 drug is contraindicated for the patient (e.g. renal impairment, uncontrolled hypertension, history of arrhythmias, or drug interactions).
- 2. Documented Adverse Reaction
- The patient has previously experienced a severe adverse event, physical harm, or intolerable gastrointestinal side effects from the required drug.
- 3. Previous Trial & Failure
- The patient previously tried the step-1 medication for an adequate trial duration (under their current or a previous health plan) without clinical efficacy.
- 4. Expected Ineffectiveness
- Based on sound clinical evidence or the patient's medical characteristics, the step-1 medication is reasonably expected to be ineffective.
- 5. Treatment Stability
- The patient is already stable on the prescribed GLP-1, and switching to a step-1 medication would disrupt therapeutic stability or cause physical harm.
Statutory Decision Deadlines
Where a state statute pins a decision clock, the windows below are the ones most commonly legislated — but only a minority of reform states pin these exact numbers, some use others (48 hours, for example), and many set no deadline at all. Self-funded ERISA plans follow federal prior-authorization turnarounds instead (those are on the appeals page). Look up your state before counting on a clock:
Statutes that set a standard-request deadline most often require a written decision within 72 hours of complete clinical documentation. A few deem an unanswered request granted after the deadline — most do not, so never rely on silence.
Where a delay would seriously jeopardize the patient's health, statutes that set an expedited deadline most often require a decision within 24 hours.
State-by-state provisions: steptherapy.com's legislation tracker.
Sample Prescriber Override Attestation
Physicians can include this override paragraph in their prior authorization submission or appeal letter:
Look Up Your PBM's Step Therapy Policy
Inspect verified insurer criteria and federal appeal rights:
Browse PBM Formulary Policies
See exact step therapy criteria and exception forms for CVS Caremark, Express Scripts, and Optum Rx.
Check Appeal Deadlines & Rights
Internal appeal deadlines by coverage type, decision turnarounds, and external independent review rights — from primary federal sources.